K
Katharina Gauss
Researcher at University of Tübingen
Publications - 8
Citations - 1732
Katharina Gauss is an academic researcher from University of Tübingen. The author has contributed to research in topics: Parkinson's disease & Diffusion MRI. The author has an hindex of 6, co-authored 8 publications receiving 1315 citations. Previous affiliations of Katharina Gauss include German Center for Neurodegenerative Diseases.
Papers
More filters
Journal ArticleDOI
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek,Danna Jennings,Shirley Lasch,Andrew Siderowf,Caroline M. Tanner,Tanya Simuni,Christopher S. Coffey,Karl Kieburtz,Emily Flagg,Sohini Chowdhury,Werner Poewe,Brit Mollenhauer,Todd Sherer,Mark Frasier,Claire Meunier,Alice Rudolph,Cindy Casaceli,John Seibyl,Susan Mendick,Norbert Schuff,Ying Zhang,Arthur W. Toga,Karen Crawford,Alison Ansbach,Pasquale De Blasio,Michele Piovella,John Q. Trojanowski,Les Shaw,Andrew B. Singleton,Keith A. Hawkins,Jamie L. Eberling,David W. Russell,Laura Leary,Stewart A. Factor,Barbara Sommerfeld,Penelope Hogarth,Emily Pighetti,Karen Williams,David G. Standaert,Stephanie Guthrie,Robert A. Hauser,Holly Delgado,Joseph Jankovic,Christine Hunter,Matthew B. Stern,Baochan Tran,James B. Leverenz,Marne Baca,Sam Frank,Cathi A. Thomas,Irene H. Richard,Cheryl Deeley,Linda Rees,Fabienne Sprenger,Elisabeth Lang,Holly A. Shill,Sanja Obradov,Hubert H. Fernandez,Adrienna Winters,Daniela Berg,Katharina Gauss,Douglas Galasko,Deborah Fontaine,Zoltan Mari,Melissa Gerstenhaber,David J. Brooks,Sophie Malloy,Paolo Barone,Katia Longo,Tom Comery,Bernard Ravina,Igor D. Grachev,Kim Gallagher,Michelle Collins,Katherine Widnell,Suzanne Ostrowizki,Paulo Fontoura,F. Hoffmann La-Roche,Tony W. Ho,Johan Luthman,Marcel P. van der Brug,Alastair D. Reith,Peggy Taylor +82 more
TL;DR: The Parkinson Progression Marker Initiative (PPMI) is a comprehensive observational, international, multi-center study designed to identify PD progression biomarkers both to improve understanding of disease etiology and course and to provide crucial tools to enhance the likelihood of success of PD modifying therapeutic trials.
Journal ArticleDOI
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
Ju-Hee Kang,Ju-Hee Kang,David J. Irwin,Alice Chen-Plotkin,Andrew Siderowf,Chelsea Caspell,Christopher S. Coffey,Teresa Waligorska,Peggy Taylor,Sarah Pan,Mark Frasier,Kenneth Marek,Karl Kieburtz,Danna Jennings,Tanya Simuni,Caroline M. Tanner,Andrew B. Singleton,Arthur W. Toga,Sohini Chowdhury,Brit Mollenhauer,John Q. Trojanowski,Leslie M. Shaw,Shirley Lasch,Emily Flagg,Werner Poewe,Todd Sherer,Claire Meunier,Alice Rudolph,Cindy Casaceli,John Seibyl,Susan Mendick,Norbert Schuff,Liz Uribe,Jon W. Yankey,Karen Crawford,Alison Scutti,Paola Casalin,Giulia Malferrari,Keith A. Hawkins,David W. Russell,Laura Leary,Stewart A. Factor,Barbara Sommerfeld,Penelope Hogarth,Emily Pighetti,Karen Williams,David Standaert,Stephanie Guthrie,Robert A. Hauser,Joseph Jankovic,Christine Hunter,Matthew B. Stern,Abigail Darin,James B. Leverenz,Marne Baca,Sam Frank,Cathi-Ann Thomas,Irene Richard,Cheryl Deeley,Linda Rees,Fabienne Sprenger,Wolfgang Oertel,Diana Willeke,Holly A. Shill,Hubert H. Fernandez,Jennifer Mule,Daniela Berg,Katharina Gauss,Douglas Galasko,Deborah Fontaine,Zoltan Mari,Arita McCoy,David Brooks,Bina Shah,Paolo Barone,Stuart Isaacson,Angela James,Alberto J. Espay,Kristy J. Espay,Dominic B. Rowe,Madelaine Ranola +80 more
TL;DR: It is found that measures of CSF Aβ1-42, T-t Tau, P-tau181, and α-synuclein have prognostic and diagnostic potential in early-stage PD.
Journal ArticleDOI
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits
Norbert Schuff,I-Wei Wu,Shannon Buckley,Eric D. Foster,Christopher S. Coffey,Darren R. Gitelman,Susan Mendick,John Seibyl,Tanya Simuni,Yu Zhang,Joseph Jankovic,Christine Hunter,Caroline M. Tanner,Caroline M. Tanner,Linda Rees,Stewart A. Factor,Daniela Berg,Isabel Wurster,Katharina Gauss,Fabienne Sprenger,Klaus Seppi,Werner Poewe,Brit Mollenhauer,Susanne Knake,Zoltan Mari,Arita McCoy,Madelaine Ranola,Kenneth Marek +27 more
TL;DR: The main goals were to replicate previous findings of abnormal diffusion imaging values from the substantia nigra and determine whether nigral diffusion alterations are associated with dopamine deficits in Parkinson's disease patients and healthy control subjects.
Journal ArticleDOI
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
Inga Liepelt-Scarfone,Katharina Gauss,Walter Maetzler,Katharina Müller,Christian Bormann,Monika Fruhmann Berger,Maarten Timmers,Johannes Streffer,Daniela Berg +8 more
TL;DR: Whether the HRPD group indeed suffers from early, PD-specific neurodegeneration remains to be verified in the ongoing follow-up examinations, as well as a promising study design to assess progression to motor PD.
Journal ArticleDOI
Autonomic dysfunction in subjects at high risk for Parkinson’s disease
Inga Liepelt-Scarfone,Andrea Pilotto,Andrea Pilotto,Katharina Müller,Christian Bormann,Katharina Gauss,Isabel Wurster,Johannes Streffer,Daniela Berg +8 more
TL;DR: The results support the presence of urinary and bowel dysfunction in subjects at high risk for motor PD and understanding the progression of non-motor aspects in PD might offer the possibility to use them as targets for disease-modifying therapies.